Concepedia

Publication | Closed Access

Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group.

24

Citations

0

References

1997

Year

I. Caesar, M.P. Roth, Tilo Andus, C Schmidt, R. Raedsch, Audrey Weber, M Gierend, K. Ewe, Jürgen Schölmerich
PubMed

Abstract

Budesonide could be an alternative to conventional steroid treatment in patients with active Crohn's disease.